Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma.
about
Polarity gene alterations in pure invasive micropapillary carcinomas of the breastAnti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice.MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.Prognostic Value of MicroRNA-182 in Cancers: A Meta-AnalysisRole of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells.Nogo-C regulates cardiomyocyte apoptosis during mouse myocardial infarctionMicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.HMGA2 and high-grade serous ovarian carcinoma.Targeting mitotic pathways for endocrine-related cancer therapeutics.Posttranscriptional regulation of FOXO expression: microRNAs and beyond.miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.
P2860
Q33892823-7FA2BA81-8EF9-46F2-A592-3C334BED9223Q33895739-FA325375-B19A-4A18-B082-183E3F9D3F09Q34450694-1C1B304B-1B5D-428C-8EE3-C5CE24EEBCC0Q35630616-981023D2-5FDA-427D-88C2-DF368B31B322Q36629479-D4CA82A5-4F11-4F2D-B448-1749717141F3Q37465955-76DAD229-FDF4-496C-8D52-39C3886CF3DCQ37699375-A44F21E0-76B1-494A-9B6B-2057B1A04868Q38107833-6B2D9B14-C40E-481B-AE47-F6AC39654A63Q38671036-AAD532A5-5AF0-47F5-AB95-FF446F3DB16CQ38752093-1486D58A-247D-4316-9759-CE17F8DF9EBBQ39254996-73D2DB3F-8787-452B-9B90-A988CB991E61Q49593669-90A8D763-D8CF-44FA-A5BC-335DF26BBAB4
P2860
Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@ast
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@en
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@nl
type
label
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@ast
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@en
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@nl
prefLabel
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@ast
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@en
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@nl
P2093
P2860
P1433
P1476
Expression analysis of MIR182 ...... in advanced ovarian carcinoma.
@en
P2093
Barbara M Buttin
Brian D McMillen
Denise M Scholtens
Irene B Helenowski
Jian-Jun Wei
Margarita M Aponte
Zhaojian Liu
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.118
P577
2012-07-13T00:00:00Z
P5875
P6179
1050577171